osteoporosis /newsroom/taxonomy/term/2806/all en Monzur Murshed /newsroom/monzur-murshed Fri, 21 Oct 2022 16:47:53 +0000 lawrence.chiang@mail.mcgill.ca 288447 at /newsroom A new 'atlas' of genetic influences on osteoporosis /newsroom/channels/news/new-atlas-genetic-influences-osteoporosis-292859 <p>A ground-breaking new study led by researchers from the Lady Davis Institute (LDI) at the Jewish General Hospital (JGH) has succeeded in compiling an atlas of genetic factors associated with estimated bone mineral density (BMD), one of the most clinically relevant factors in diagnosing osteoporosis. The paper, published in Nature Genetics, identifies 518 genome-wide loci, of which 301 are newly discovered, that explain 20% of the genetic variance associated with osteoporosis.</p> Thu, 03 Jan 2019 15:36:56 +0000 laurie.devine@mcgill.ca 128200 at /newsroom New genetics findings unravel key components of fracture risk in osteoporosis /newsroom/channels/news/new-genetics-findings-unravel-key-components-fracture-risk-osteoporosis-289107 <p>The largest study ever to investigate the genetics of osteoporosis and fracture risk determined that only two examined factors – bone mineral density (BMD) and muscle strength – play a potentially causal role in the risk of suffering osteoporotic fracture, a major health problem affecting more than 9 million people worldwide very year. Other clinical risk factors like vitamin D levels and calcium intake, historically considered to be crucial mediators of fracture, were not found to directly predispose people in the general population to fracture. This research was published in the BMJ.</p> Wed, 29 Aug 2018 15:42:36 +0000 laurie.devine@mcgill.ca 78585 at /newsroom Clinical trial of novel approach to treating osteoporosis represents “significant breakthrough,” according to clinician-scientist at the Lady Davis Institute /newsroom/channels/news/clinical-trial-novel-approach-treating-osteoporosis-represents-significant-breakthrough-according-283574 <p>A regimen of a novel bone anabolic medication (which builds bone mass) followed by an antiresorptive agent (which maintains bone mass) has been shown to significantly reduce the risk of fracture among post-menopausal women with severe osteoporosis, according to results of a clinical trial published in <em>The New England Journal of Medicine</em>.</p> Thu, 21 Dec 2017 20:06:47 +0000 priya.pajel@mail.mcgill.ca 32812 at /newsroom Suzanne Morin /newsroom/suzanne-morin Tue, 26 Feb 2019 16:59:44 +0000 Anonymous 22726 at /newsroom Svetlana Komarova /newsroom/svetlana-komarova Tue, 26 Feb 2019 16:59:44 +0000 Anonymous 23224 at /newsroom David Goltzman /newsroom/david-goltzman Tue, 26 Feb 2019 16:59:44 +0000 Anonymous 23794 at /newsroom ƻԺ announces 2015 Bloomberg Manulife Prize winner /newsroom/channels/news/mcgill-announces-2015-bloomberg-manulife-prize-winner-256983 <p>$50,000 research award to promote active health goes to Dr. Lora Giangregorio, whose work has led to the development of internationally endorsed exercise guidelines for osteoporosis, and tools for physicians, physiotherapists and patients  Tue, 24 Nov 2015 18:25:00 +0000 nima.adibpour@mail.mcgill.ca 24871 at /newsroom Novel gene implicated in osteoporosis /newsroom/channels/news/novel-gene-implicated-osteoporosis-255200 <p> Mon, 14 Sep 2015 14:03:44 +0000 laurie.devine@mcgill.ca 24465 at /newsroom Melatonin makes old bones stronger /newsroom/channels/news/melatonin-makes-old-bones-stronger-236832 <p> Mon, 26 May 2014 14:22:56 +0000 raphael.larocque-cyr@mcgill.ca 20789 at /newsroom Calcium supplements linked to longer lifespans in women /newsroom/channels/news/calcium-supplements-linked-longer-lifespans-women-226845 Wed, 22 May 2013 19:02:42 +0000 christopher.chipello@mcgill.ca 18682 at /newsroom